Brief: DocGo Q2 Revenue USD 164.9 Million Vs. IBES Estimate USD 162.6 Million
Aug 07 (Reuters) - DocGo Q2 net income USD 5.9 million vs. IBES estimate USD 6.01 million. * Q2 adjusted EBITDA USD 17.2 million vs. IBES estimate USD 16.9 million * Q2 gross margin 31.3% * outlook FY adjusted EBITDA USD 65-75 million
Recent news on DocGo
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
U.S. STOCKS ON THE MOVE-Dynatrace, Duolingo, Baidu Inc
DocGo slips on tepid quarterly results, narrower annual outlook